Search research articles
Contact Us
Filters
Showing results (21-30 of 44) with videos related to
Page
of 5
Sort By:
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
|
June 7, 2019
SIZE OF THE LARGEST METASTATIC FOCUS TO THE LYMPH NODE IS ASSOCIATED WITH INCOMPLETE RESPONSE OF PN1 PAPILLARY THYROID CARCINOMA
Yuying Deng, Guoquan Zhu, Wei Ouyang, et al.
Oncology Reports
|
March 24, 2021
Therapeutic potential of endogenous hydrogen sulfide inhibition in breast cancer (Review)
Ming Li, Ya Liu, Yuying Deng, et al.
Food & Function
|
September 3, 2021
Dandelion root extract affects ESCC progression <i>via</i> regulating multiple signal pathways
Xiaofang Duan, Limin Pan, Yuying Deng, et al.
Journal of Hazardous Materials
|
March 8, 2025
Bifunctional chitosan/tannin aerogel for gold recovery via electrostatic attraction and in-situ reduction
Kaiyan Wu, Wei Wang, Yuying Deng, et al.
Journal of Cellular Physiology
|
January 9, 2019
MicroRNA-375-3p inhibitor suppresses angiotensin II-induced cardiomyocyte hypertrophy by promoting lactate dehydrogenase B expression
Huijuan Feng, Juqing Wu, Pan Chen, et al.
Journal of Chromatography. A
|
May 6, 2025
Prediction of HPLC chromatograms under linear and curved gradient elution by linear gradient trials with initial hold time
Weiqiang Hao, Jie Tang, Yuying Deng, et al.
Annals of the New York Academy of Sciences
|
September 10, 2025
Association Between Body Composition and Obesity Phenotypes in Children and Adolescents
Yuying Deng, Miao Chen, Ziwei Huang, et al.
International Journal of Oncology
|
August 25, 2022
Activation of DDX58/RIG‑I suppresses the growth of tumor cells by inhibiting STAT3/CSE signaling in colon cancer
Yuying Deng, Han Fu, Xue Han, et al.
The Lancet. Diabetes & Endocrinology
|
October 30, 2025
Efficacy and safety of tirzepatide added to basal insulin in patients with type 2 diabetes in China (SURPASS-CN-INS): a double-blind, multicentre, randomised, placebo-controlled, phase 3 trial
Lixin Guo, Xiaolin Dong, Jianhua Ma, et al.
Endocrine Connections
|
May 10, 2019
Clinical significance of the BRAFV600E mutation in PTC and its effect on radioiodine therapy
Guoquan Zhu, Yuying Deng, Liqin Pan, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 44) with videos related to
Sort By:
Page
of 5
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
|
June 7, 2019
SIZE OF THE LARGEST METASTATIC FOCUS TO THE LYMPH NODE IS ASSOCIATED WITH INCOMPLETE RESPONSE OF PN1 PAPILLARY THYROID CARCINOMA
Yuying Deng, Guoquan Zhu, Wei Ouyang, et al.
Oncology Reports
|
March 24, 2021
Therapeutic potential of endogenous hydrogen sulfide inhibition in breast cancer (Review)
Ming Li, Ya Liu, Yuying Deng, et al.
Food & Function
|
September 3, 2021
Dandelion root extract affects ESCC progression <i>via</i> regulating multiple signal pathways
Xiaofang Duan, Limin Pan, Yuying Deng, et al.
Journal of Hazardous Materials
|
March 8, 2025
Bifunctional chitosan/tannin aerogel for gold recovery via electrostatic attraction and in-situ reduction
Kaiyan Wu, Wei Wang, Yuying Deng, et al.
Journal of Cellular Physiology
|
January 9, 2019
MicroRNA-375-3p inhibitor suppresses angiotensin II-induced cardiomyocyte hypertrophy by promoting lactate dehydrogenase B expression
Huijuan Feng, Juqing Wu, Pan Chen, et al.
Journal of Chromatography. A
|
May 6, 2025
Prediction of HPLC chromatograms under linear and curved gradient elution by linear gradient trials with initial hold time
Weiqiang Hao, Jie Tang, Yuying Deng, et al.
Annals of the New York Academy of Sciences
|
September 10, 2025
Association Between Body Composition and Obesity Phenotypes in Children and Adolescents
Yuying Deng, Miao Chen, Ziwei Huang, et al.
International Journal of Oncology
|
August 25, 2022
Activation of DDX58/RIG‑I suppresses the growth of tumor cells by inhibiting STAT3/CSE signaling in colon cancer
Yuying Deng, Han Fu, Xue Han, et al.
The Lancet. Diabetes & Endocrinology
|
October 30, 2025
Efficacy and safety of tirzepatide added to basal insulin in patients with type 2 diabetes in China (SURPASS-CN-INS): a double-blind, multicentre, randomised, placebo-controlled, phase 3 trial
Lixin Guo, Xiaolin Dong, Jianhua Ma, et al.
Endocrine Connections
|
May 10, 2019
Clinical significance of the BRAFV600E mutation in PTC and its effect on radioiodine therapy
Guoquan Zhu, Yuying Deng, Liqin Pan, et al.
Page
of 5